Principal Financial Group Inc Corbus Pharmaceuticals Holdings, Inc. Transaction History

Principal Financial Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$0.6 - $1.11 $14,892 - $27,550	-24,820 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$1.01 - $1.82 $4,062 - $7,320	-4,022 Reduced 13.94%	24,820 $25,000
Q2 2021 Aug 10, 2021	SELL	$1.39 - $2.21 $4,915 - $7,814	-3,536 Reduced 10.92%	28,842 $52,000
Q1 2021 May 10, 2021	SELL	$1.27 - $3.42 $996 - $2,684	-785 Reduced 2.37%	32,378 $64,000
Q4 2020 Feb 08, 2021	BUY	$0.94 - $1.89 $7,457 - $14,995	7,934 Added 31.45%	33,163 $41,000
Q3 2020 Nov 06, 2020	SELL	$1.5 - $9.38 $1,465 - $9,164	-977 Reduced 3.73%	25,229 $45,000
Q2 2020 Aug 05, 2020	BUY	$4.79 - $8.39 $125,526 - $219,868	26,206 New	26,206 $220,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.